Macrophages Phenotype Regulated by IL-6 Are Associated with the Prognosis of Platinum-Resistant Serous Ovarian Cancer: Integrated Analysis of Clinical Trial and Omics

• Published in: Journal of immunology research 2023-04, Vol.2023, p.6455704-15
• Main Authors: Wu, Xiaoqing, Lu, Wenping, Xu, Chaojie, Jiang, Cuihong, Zhuo, Zhili, Wang, Ruipeng, Zhang, Dongni, Cui, Yongjia, Chang, Lei, Zuo, Xi, Wang, Ya’nan, Mei, Heting, Zhang, Weixuan, Zhang, Mengfan, Li, Chen
• Format: Article
• Language: English
• Subjects: Ascites; B7-1 Antigen; Cancer therapies; Carcinoma, Ovarian Epithelial; CD80 antigen; Chemokines; Chemotherapy; Clinical trials; Cohort analysis; Cohort Studies; Correlation analysis; Disease; Female; Flow cytometry; Gene expression; Gene set enrichment analysis; Genomes; Genotype & phenotype; Hospitals; Humans; Immunology; Interleukin 6; Interleukin-6 - genetics; Macrophages; Medical prognosis; Metastases; Ovarian cancer; Ovarian Neoplasms - genetics; Patients; Peripheral blood; Phenotypes; Platinum; Polarization; Prognosis; Stat3 protein; Survival analysis; Tumor microenvironment; Tumor Microenvironment - genetics; Tumors
• ISSN: 2314-8861; 2314-7156
• DOI: 10.1155/2023/6455704

Background. The treatment of platinum-resistant recurrent ovarian cancer (PROC) is a clinical challenge and a hot topic. Tumor microenvironment (TME) as a key factor promoting ovarian cancer progression. Macrophage is a component of TME, and it has been reported that macrophage phenotype is related to the development of PROC. However, the mechanism underlying macrophage polarization and whether macrophage phenotype can be used as a prognostic indicator of PROC remains unclear. Methods. We used ESTIMATE to calculate the number of immune and stromal components in high-grade serous ovarian cancer (HGSOC) cases from The Cancer Genome Atlas database. The differential expression genes (DEGs) were analyzed via protein–protein interaction network, Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene ontology (GO) analysis to reveal major pathways of DEGs. CD80 was selected for survival analysis. IL-6 was selected for gene set enrichment analysis (GSEA). A subsequent cohort study was performed to confirm the correlation of IL-6 expression with macrophage phenotype in peripheral blood and to explore the clinical utility of macrophage phenotype for the prognosis of PROC patients. Results. A total of 993 intersecting genes were identified as candidates for further survival analysis. Further analysis revealed that CD80 expression was positively correlated with the survival of HGSOC patients. The results of GO and KEGG analysis suggested that macrophage polarization could be regulated via chemokine pathway and cytokine–cytokine receptor interaction. GSEA showed that the genes were mainly enriched in IL-6-STAT-3. Correlation analysis for the proportion of tumor infiltration macrophages revealed that M2 was correlated with IL-6. The results of a cohort study demonstrated that the regulation of macrophage phenotype by IL-6 is bidirectional. The high M1% was a protective factor for progression-free survival. Conclusion. Thus, the macrophage phenotype is a prognostic indicator in PROC patients, possibly via a hyperactive IL-6-related pathway, providing an additional clue for the therapeutic intervention of PROC.